Repeated esophageal cancer in patients with oral squamous cell carcinoma
Conditions
Interventions
Gold Standard:Pathology
Index test:Image enhanced endoscopic technology
Sponsors
Shanghai Ninth Peoples’ Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Newly diagnosed oral squamous cell carcinoma patients who have been clinically diagnosed have pathological evidence and clinical staging meets the indications for radical surgical treatment; (2) Between the ages of 18 and 85; (3) Sign an informed consent form, cooperate with follow-up and review, and have good compliance.
Exclusion criteria
Exclusion criteria: (1) Other oral tumors confirmed by pathology as non squamous cell carcinoma; (2) Previous history of oral squamous cell carcinoma surgery and radiation therapy; (3) Previous history of digestive tract tumors such as esophagus and stomach; (4) Individuals with contraindications for gastrointestinal endoscopy examination; (5) Individuals with severe primary diseases such as cardiovascular, cerebrovascular, pulmonary, hepatic, renal, and hematopoietic systems (6) Individuals with abnormal mental states (such as anxiety, depression, schizophrenia, etc.); Individuals who are unable to fully obtain informed consent due to intellectual or behavioral impairments; (7) Pregnant or lactating women; (8) Individuals with a history of iodine allergy or hyperthyroidism are not suitable for iodine staining examination; (9) Frequent changes in work environment or place of residence or other situations that may lead to loss of access; Patients participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity;Specificity;positive predictive value ; | — |
Countries
China
Contacts
Public ContactLei Wang
Shanghai Ninth Peoples’ Hospital, Shanghai Jiao Tong University School of Medicine
Outcome results
None listed